ALGN vs COLL: fair value comparison
Align Technology, Inc. and Collegium Pharmaceutical, Inc. · Updated 2026-09-12
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, ALGN currently sits closer to the top of our discount ranking.
| ALGN | COLL | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $150.82 | $24.00 |
| 12-month range | $137.88–$189.02 | $24.00–$47.11 |
| Sector rank | #12 of 113 Healthcare | #16 of 113 Healthcare |
| Quality grade | B | B |
| Leverage | Low | High |
| Margin trend | Contracting | Expanding |
| Revenue growth | Modest | Strong |
| RSI zone | Oversold | Neutral |
| 50/200-day trend | Downtrend | Downtrend |
| DCF cross-check | Overvalued | Undervalued |
| 52-week position | The lower-middle quarter | The bottom quarter |
Full single-stock breakdowns: ALGN fair value analysis · COLL fair value analysis